Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Safety & Availability (Biologics)

Safety & Availability (Biologics)

                        Biologic Product Security
          Blood Safety & Availability
          CBER-Regulated Products: Shortages and Discontinuations
          Pandemics & Emerging Diseases
          Tissue Safety & Availability
          Vaccine Safety & Availability


                        HIV Home Test Kits
          Recalls (Biologics)
          Report a Problem to the Center for Biologics Evaluation & Research Home
          Vaccines, Blood & Biologics
          Safety & Availability (Biologics)
          Keeping Blood Transfusions Safe:  FDA's Multi-layered Protections for Donated BloodSafety & Availability (Biologics) Keeping Blood Transfusions Safe:  FDA's Multi-layered Protections for Donated Blood
  
  	
    Share
    Post
    Linkedin

    Email
    PrintKeeping the United States blood supply the world's safest is the ultimate responsibility of the nation's blood establishments that collect and process the units of whole blood donated by volunteers each year. The Food and Drug Administration, however, has the vital role of ensuring that patients who receive a blood transfusion are protected by multiple overlapping safeguards. This FDA blood-safety system includes measures in the following areas:

Donor screening
	Blood testing
	Donor deferral lists
	Quarantine
	Problems and DeficienciesDonor screening:Donor screening plays an important role in ensuring the safety of the U.S. blood supply. FDA regulations require that a donor be free from any disease transmissible by blood transfusion, in so far as can be determined by health history and examination.

Donors are informed about potential risks and are required to answer questions about factors that may have a bearing on the safety of their blood. For example, donors with a history of intravenous drug abuse are routinely deferred.

In addition to federal regulations, FDA periodically issues guidance documents providing recommendations to decrease the potential for transmission of infectious diseases when new information or testing methodologies becomes available. For example, since November 1999, the FDA has recommended that the blood industry defer potential donors who have lived in the United Kingdom and other European countries to reduce the risk of variant Creutzfeldt-Jakob disease (vCJD), the human form of "mad cow disease."

**Blood testing:** The FDA reviews and approves all test kits used to detect infectious diseases in donated blood. After donation, each unit of donated blood is required to undergo a series of tests for infectious diseases, including:

Hepatitis B and C viruses

Human Immunodeficiency Virus, Types 1 and 2

Human T-Lymphotropic Virus, Types I and II

*Treponema pallidum* (Syphilis)

Additionally, FDA recommends testing for the following infectious diseases:

West Nile Virus

*Trypanosoma cruzi* (Chagas disease)

**Donor deferral lists:** Blood establishments must keep current a list of deferred donors and use it to make sure that they do not collect blood from anyone on the list.

**Quarantine:** Donated blood must be quarantined until it is tested and shown to be free of infectious agents.

**Problems and deficiencies:** Blood centers must investigate manufacturing problems, correct all deficiencies, and notify the FDA when product deviations occur in distributed products.

If any one of these safeguards is breached, the blood component is considered unsuitable for transfusion and is subject to recall.

Related Information

Blood & Blood Products

                                                                                  Content current as of:
      03/23/2018
              
              
Regulated Product(s)
		 Biologics
			  			     			  						              
			
			 
			  Blood ProductsSafety & Availability (Biologics)

          
                        Biologic Product Security
          Blood Safety & Availability
          CBER-Regulated Products: Shortages and Discontinuations
          Pandemics & Emerging Diseases
          Tissue Safety & Availability
          Vaccine Safety & Availability


                        HIV Home Test Kits
          Recalls (Biologics)
          Report a Problem to the Center for Biologics Evaluation & Research
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop